Filed Under: Law & Policy
A medical marijuana dispensary in Florida can now receive federal registration to handle marijuana treated as Schedule III.
A dispensary serving legal medical patients in Minnesota can face a proposed federal denial.
Both can be licensed by their states. Both can sell cannabis to patients who qualify under state law. The difference is that Washington has begun deciding which state medical marijuana systems fit the federal government’s new rules and which ones do not.
That is the part of marijuana rescheduling that has received far less attention.
On October 30, the Justice Department announced that more than 900 dispensaries in Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia had received DEA registrations after successful pre-registration investigations. DOJ also made clear that a state medical marijuana license does not guarantee federal approval.
Industry reporting published November 11 identified businesses operating under medical marijuana systems in Minnesota, California, Illinois, Washington, D.C., and other jurisdictions as facing DEA orders to show cause or other action toward proposed denial. Some of those orders have circulated among attorneys and reporters but have not been publicly posted by the DEA, so their procedural status matters. An order to show cause is not automatically a final rejection.
The larger pattern is already visible without pretending every case has been decided.
The federal government says it is recognizing medical marijuana. In practice, it is recognizing medical marijuana on federal terms, and those terms can favor states that kept their medical systems more restricted or more clearly separated from recreational cannabis.
States that built broader access or combined medical and adult-use cannabis under the same regulatory roof can have a harder time fitting through the federal door.
To understand why, forget the usual shorthand that marijuana was simply “moved to Schedule III.” That is not what happened.
Acting Attorney General Todd Blanche’s April order created Schedule III treatment for FDA-approved drug products containing marijuana and marijuana handled under qualifying state medical marijuana systems. Marijuana outside those categories remains in Schedule I. Hemp remains excluded from the federal definition of marijuana.
The federal rule also created an expedited registration process for qualifying state medical businesses.
That registration is the gatekeeper.
The Controlled Substances Act already gives DEA authority over businesses handling federally controlled drugs. Under the new marijuana framework, DEA must register qualifying applicants unless it finds registration inconsistent with the public interest or U.S. obligations under the Single Convention on Narcotic Drugs.
In plain English, a state can say a business is perfectly legal while DEA can still say its version of medical marijuana does not qualify for the new federal system.
DEA is looking at more than whether a dispensary has a license hanging on the wall. The federal rules examine safeguards against diversion, recordkeeping, reporting, inspections, and the documentation used to establish that a patient qualifies for medical cannabis. DEA is also concerned with keeping Schedule III medical activity separate from recreational marijuana, which remains federally prohibited.
That distinction puts some states in a difficult position because marijuana regulation has spent years moving in the opposite direction.
Medical legalization came first in many places. Adult-use legalization followed. States then began combining regulators, licenses, and retail systems because maintaining two completely separate cannabis markets could be expensive and unnecessary under state law.
Federal recognition now gives some businesses a reason to pull those systems apart again.
Minnesota shows how this works.
Attorneys who reviewed a DEA order to show cause involving a Minnesota dispensary identified three separate federal objections. One concerned the state’s licensing structure for medical and adult-use cannabis. Another involved Minnesota’s alternative medical-certification process for veterans. The third involved artificially derived cannabinoids that Minnesota permits while synthetic THC remains Schedule I under federal law. Dickinson Wright attorneys who reviewed the order described those objections.
Minnesota’s veterans rule can be verified directly in state law. Most patients must submit certification from a health care practitioner. Veterans have a separate route. Minnesota law allows the state to use an alternative procedure that can include a veteran identification card and an attestation that the veteran has been diagnosed with a qualifying medical condition.
Minnesota considers that enough for its medical program.
The federal government may not.
The conflict over combined medical and recreational licensing is just as important. If a business serves both markets, DEA must determine whether the marijuana being handled under federal Schedule III rules can remain separate from recreational sales that federal law still prohibits.
That is where a policy built by one government runs directly into the policy of another.
Illinois makes the conflict even easier to see.
Its law allows a Medical Cannabis Dispensing Organization License to be issued to the same entity holding an Adult Use Dispensing Organization License at the same address. Illinois law says so directly.
For Illinois, putting medical and recreational cannabis in the same business can be a feature of the regulatory system.
For DEA, it can create a problem because federal law does not treat those two categories of marijuana equally. Medical marijuana handled under the qualifying federal framework may be treated as Schedule III. Adult-use marijuana remains Schedule I.
Illinois also allows qualifying veterans receiving care through the Department of Veterans Affairs to participate in the medical program without the standard written certification from a health professional. Illinois regulations confirm that exception. That state pathway becomes another issue when DEA applies federal documentation requirements.
California has a different problem.
The state allows patients to establish medical eligibility using written documentation from portions of a physician’s medical records showing that the patient has a serious medical condition and that medicinal cannabis is appropriate. California does not require one mandatory certification form. The California Department of Public Health confirms both points.
The federal rule is more specific about what qualifying documentation must contain. Patient and practitioner information must be included, and the document must be signed and dated when issued.
DEA has reportedly objected when California documentation does not satisfy those requirements.
This is where the federal policy starts affecting state behavior.
California’s Department of Cannabis Control adopted emergency regulations allowing businesses with combined medical and adult-use authority to split those operations into separate licenses. Under certain conditions, those licenses can even be issued to different legal entities. California is now working through regular rulemaking to make the arrangement permanent.
The department reported that 95 businesses had already used the separation process by November.
California was not ordered by DEA to redesign its licensing system. It did not need to be.
If federal registration has enough value, businesses have an incentive to restructure themselves so the medical side looks more like the system Washington is willing to recognize.
Washington, D.C., shows the same tension from the patient-access side.
M O R E F R O M P O T C U L T U R E M A G A Z I N E
Felons Need Not Apply
DEA cannabis rules are colliding with state programs built around second chances. In Mississippi, two dispensary workers with old controlled-substance felony records became a federal compliance problem when their employer sought Schedule III registration. Pot Culture Magazine follows the waiver rules, the social-equity contradiction, and the question legalization still has not answered: when does a…
Cannabis Lies Vol. 23: The IQ Lie
In Cannabis Lies Vol. 23, federal agencies turn an eight-point IQ finding into a sweeping warning about adolescent cannabis use. The number came from only 23 persistent adolescent-onset users in a New Zealand cohort. PCM returns to the original research, follows the claim into American policy, and exposes how scientific nuance became drug-war propaganda.
Adults 21 and older in the District can self-certify that they use cannabis for medical purposes instead of obtaining a traditional practitioner recommendation. District law expressly allows that approach.
D.C. made medical access easier.
The federal framework demands more documentation.
Neither government has to change its definition for the conflict to exist. A patient can remain completely legal under D.C. law while the business serving that patient has trouble satisfying DEA’s federal standards.
This is why the new divide is bigger than medical marijuana versus recreational marijuana.
Washington is now sorting medical programs against other medical programs.
States that kept medical cannabis tightly controlled and structurally separate from recreational sales may fit more easily into the federal system. States that expanded access, created exceptions or integrated medical marijuana with adult-use cannabis can face additional federal obstacles.
Several states now facing federal friction built expansive or integrated cannabis systems. California, Illinois and Minnesota all chose regulatory approaches that go beyond the narrower medical-only model. The federal government is now making access to its Schedule III system depend on whether those state choices satisfy Washington.
The pressure does not stop with licensing.
DEA is also beginning to define who federally recognized medical marijuana businesses should buy from and sell to.
Its October 30 guidance says timely applicants and registered businesses should conduct Schedule III medical marijuana transactions only with other timely applicants or DEA registrants. Businesses are expected to verify their trading partners and maintain compliant supply chains by November 29, 2026. DEA’s guidance warns that transactions outside that system could become grounds for denying an application or revoking a registration.
DEA also includes an important disclaimer:
“The contents of this document do not have the force and effect of law and are not meant to bind the public in any way.”
November 29 is therefore not a statutory or regulatory deadline created by the guidance. It is the date DEA says timely applicants are expected to have verified their trading partners and established compliant supply chains.
What DEA is describing is the beginning of a separate federal lane for medical marijuana.
A state-licensed business that enters that lane cannot assume everything else about its operation changes with it. Federal registration does not legalize recreational marijuana. It does not wipe away state restrictions. It does not give a dispensary automatic permission to move marijuana across state lines.
Missouri regulators have already told licensees to avoid importing, exporting, interstate commerce, or other activity that removes Missouri-regulated marijuana from the state’s regulated system.
The federal government is not taking the existing state marijuana market and simply stamping “Schedule III” across it.
It is carving out a smaller federally recognized medical system inside a much larger state-created cannabis economy.
That has consequences for businesses that never expected to choose between the two.
A dispensary may have to separate medical inventory from recreational inventory. It may need different licenses or corporate entities. It may have to document suppliers and customers differently. A state may decide that its current rules are worth preserving even if some businesses cannot obtain DEA registration.
Or states may start changing their programs.
California already has.
Patients remain caught in the middle even when nothing about their own legal status changes. A Minnesota veteran can still qualify under Minnesota law if DEA objects to the state’s certification system. A California patient can still be a legitimate medical patient if DEA believes the documentation accepted by California falls short of federal requirements.
The disagreement is over which system Washington is willing to recognize.
For decades, the federal government treated virtually every state marijuana program as illegal. States went ahead anyway and built their own rules for patients, doctors, businesses, and eventually recreational consumers.
Now Washington has finally opened a federal door for medical marijuana, but it is not opening that door equally to every state program.
The federal government is deciding what state medical marijuana has to look like before it will recognize it.
The next cannabis divide may not be legal states against prohibition states. It may run through the medical states themselves, separating the programs that already fit Washington’s rules from the ones that may have to change to get in.
©2026 Pot Culture Magazine. All rights reserved. This content is the exclusive property of Pot Culture Magazine and may not be reproduced, distributed, or transmitted in any form or by any means without prior written permission from the publisher, except for brief quotations in critical reviews.
F O R T H E C U L T U R E B Y T H E C U L T U R E
Do You Have a Medical Marijuana Card?
Police may ask whether you have a medical marijuana card because the answer can become evidence. Pot Culture Magazine examines recent court rulings involving cannabis odor, traffic stops, Miranda rights, searches, and medical authorization, showing what police may be trying to establish, what the law can require, and why volunteering information can work against you.
The Fight for Cannabis
Idaho, Massachusetts, and Houston faced three different cannabis votes on Election Day, but each came down to political power. Idaho voters kept the initiative route open, Massachusetts rejected a rollback of adult-use cannabis, and Houston pushed misdemeanor marijuana enforcement to the bottom of police priorities. The Fight for Cannabis asks the question underneath all three:…
The Washington Post Slept Through the Science
The Washington Post told readers that people with greater lifetime cannabis exposure slept less. But a Northwestern study found no significant link between cumulative use and shorter sleep, while recent users averaged nearly 20 minutes more. Pot Culture Magazine examines the missing context, seven-day sleep monitoring, conflicting scientific reviews, and the newspaper’s unanswered fact-checking questions.
Discover more from POT CULTURE MAGAZINE
Subscribe to get the latest posts sent to your email.
Leave a Reply